← FDA DRUG APPROVALS

FDA ANDA · ANDA075045

BUTORPHANOL TARTRATE PRESERVATIVE FREE

Sponsor: HIKMA

APPLICATION
ANDA075045
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-12
LATEST ACTION
2025-12-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

BUTORPHANOL TARTRATE PRESERVATIVE FREEPrescription
BUTORPHANOL TARTRATE 1MG/ML · INJECTABLE · INJECTION
BUTORPHANOL TARTRATE PRESERVATIVE FREEPrescription
BUTORPHANOL TARTRATE 2MG/ML · INJECTABLE · INJECTION

Approval history

2025-12-22Labeling · Supplement 18 · standardAP
2024-01-10Labeling · Supplement 16 · standardAP
2024-01-10Labeling · Supplement 17 · standardAP
2019-10-11Labeling · Supplement 15 · standardAP
2001-10-30Labeling · Supplement 3AP
2001-04-03Manufacturing (CMC) · Supplement 2AP
1999-10-15Labeling · Supplement 1AP
1998-08-12OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →